Interventional therapy for cholangiocellular carcinoma with left portal vein embolus is a method to treat tumor lesions, relieve biliary obstruction and eliminate embolus.
Cholangiocellular carcinoma often leads to embolization of portal vein, which may lead to biliary obstruction and life-threatening jaundice, while cancerous embolism of the left branch of portal vein may lead to increased portal pressure, splenomegaly, gastrointestinal hemorrhage, etc. At this time, most of the tumors are in advanced stage. At this time, most of the tumors are in advanced stage, and interventional therapy can effectively improve the quality of life and prolong the survival time.
Interventional therapy for cholangiocellular carcinoma includes placing 131I-containing stent to treat the primary lesion, percutaneous hepatic puncture to place drainage tube or stent to relieve biliary obstruction. For left portal vein thrombus, 131I-containing stent can be placed to eliminate the thrombus and recanalize the blood vessels to ensure the blood flow to the liver. However, it is easy to recur and metastasize after interventional therapy.
Consultation with the attending doctor is recommended for the interventional treatment of cholangiocellular carcinoma with thrombus in the left branch of portal vein.